James Walter Glasheen

Director/Board Member at

ForSight VISION5, Inc.

58 year

98 connections

Health Technology

Commercial Services

Consumer Services

Profile

James Walter Glasheen is currently a Director at ForSight VISION5, Inc., a Director at Epigenesis Pharmaceuticals LLC, a Managing Member at TP Management VII LLC, and a General Partner at Technology Partners.
He was previously an Independent Director at TRIA Beauty, Inc., a Director at Transcend Medical, Inc., an Independent Director at Soleno Therapeutics, Inc., an Independent Director at Revance Therapeutics, Inc., a Director at Incline Therapeutics, Inc., a Director at Elcelyx Therapeutics, Inc., a Director at Health360, Inc., a Managing Director at CIT Venture Capital, a Director at Leptos Biomedical, Inc., a Director at Essentialis, Inc., a Director at Medley Health, Inc., and a Member at McKinsey & Co., Inc. He received his undergraduate degree from Duke University and his graduate and doctorate degrees from Harvard University.

James Walter Glasheen active positions

Companies	Position	Start
Technology Partners Technology Partners Investment ManagersFinance Technology Partners invests in companies located in the United States. The firm targets companies operating in the fields of cleantech and life science sectors. It provides financing for seed, early and later stage capital requirements.	Private Equity Investor	01/01/2002
Epigenesis Pharmaceuticals LLC Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Develops inhaled respiratory medicines	Director/Board Member	-
ForSight VISION5, Inc. ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops ocular drug delivery technologies and device solutions for ophthalmic diseases	Director/Board Member	-
TP Management VII LLC TP Management VII LLC Investment Trusts/Mutual FundsMiscellaneous Part of Technology Partners, TP Management VII LLC is a company based in Palo Alto, CA.	Corporate Officer/Principal	-

All active positions of James Walter Glasheen

Former positions of James Walter Glasheen

Companies	Position	End
SOLENO THERAPEUTICS, INC.	Director/Board Member	16/10/2018
REVANCE THERAPEUTICS, INC.	Director/Board Member	01/07/2016
Health360, Inc. Health360, Inc. Medical/Nursing ServicesHealth Services Provides health services	Director/Board Member	30/01/2013
Leptos Biomedical, Inc. Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Provides medical services for chronic obesity patients	Director/Board Member	12/11/2010
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Corporate Officer/Principal	-

See the detail of James Walter Glasheen's experience

Training of James Walter Glasheen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Walter Glasheen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	18
TRIA Beauty, Inc. TRIA Beauty, Inc. Medical SpecialtiesHealth Technology Manufactures and retails hair removal and skincare devices through online	Health Technology
Transcend Medical, Inc. Transcend Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company	Health Technology
TP Management VII LLC TP Management VII LLC Investment Trusts/Mutual FundsMiscellaneous Part of Technology Partners, TP Management VII LLC is a company based in Palo Alto, CA.	Miscellaneous
Soleno Therapeutics, Inc. Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases	Health Technology
Revance Therapeutics, Inc. Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics	Health Technology
Incline Therapeutics, Inc. Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Elcelyx Therapeutics, Inc. Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation	Health Technology
Health360, Inc. Health360, Inc. Medical/Nursing ServicesHealth Services Provides health services	Health Services
ForSight VISION5, Inc. ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops ocular drug delivery technologies and device solutions for ophthalmic diseases	Electronic Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Duke University Duke University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Technology Partners Technology Partners Investment ManagersFinance Technology Partners invests in companies located in the United States. The firm targets companies operating in the fields of cleantech and life science sectors. It provides financing for seed, early and later stage capital requirements.	Finance
Epigenesis Pharmaceuticals LLC Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Develops inhaled respiratory medicines	Health Technology
CIT Venture Capital CIT Venture Capital Investment ManagersFinance CIT Venture Capital specializes in LBOs, MBOs, recapitalizations, growth financings and venture capital investments in the life science, telecommunications and technology sectors. Within the telecommunications and technology sectors, the firm seeks to invest in the following industries: communications services, wireless technologies, communications equipment, software and Internet-enabling technologies. Their life sciences investments focus on biopharmaceuticals, medical devices and pharmaceutical services. CIT Venture Capital prefers to invest in companies based in the US. For buyouts, the firm seeks to invest in transactions valued at more than $50 million, contributing at least $7.5 million in equity per transaction. For growth financings, they target companies with annual sales greater that $50 million and will contribute a minimum of $4 million in equity. For technology, communications and life sciences venture capital transactions, CIT Venture Capital invests $2 million to $15 million in equity per transaction. Their investment horizon is typically 3 to 7 years. CIT Venture Capital prefers to take majority stakes in their portfolio companies, but also considers significant minority stakes	Finance
Leptos Biomedical, Inc. Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Provides medical services for chronic obesity patients	Health Technology
Essentialis, Inc. Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases	Health Technology
Medley Health, Inc. Medley Health, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing and communications services	Commercial Services